Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. - Wikidata - awgldk - TriplyDB

Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.

Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.

http://www.wikidata.org/entity/Q33745120

about

Complement cascade and kidney transplantation: The rediscovery of an ancient enemy The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis Effector mechanisms of rejection Mannan-binding lectin in cardiovascular disease.Review: Complement and its regulatory proteins in kidney diseases.Value of plasmatic membrane attack complex as a marker of severity in acute kidney injury Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial.Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model.Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study.Heme interacts with c1q and inhibits the classical complement pathway.Enhancing complement control on endothelial barrier reduces renal post-ischemia dysfunction Complement involvement in kidney diseases: From physiopathology to therapeutical targeting Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation.Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.The role of the complement system in acute kidney injury.Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation.Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction.Role of complement and perspectives for intervention in ischemia-reperfusion damage.New strategies to optimize kidney recovery and preservation in transplantation.Overview of complement activation and regulation Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.Role of complement in glomerular diseases.Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.Innate Immunity in Systemic Sclerosis.Complement in ANCA-associated vasculitis: mechanisms and implications for management.Delayed graft function and its management in children.Macrophages as Effectors of Acute and Chronic Allograft Injury.Natural IgM antibodies are involved in the activation of complement by hypoxic human tubular cells.New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.Thrombin may modulate dendritic cell activation in kidney transplant recipients with delayed graft function.Which pathways trigger the role of complement in ischaemia/reperfusion injury?Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice.Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway.Biochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms.Emerging biomarkers in renal damage.Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys.

P2860

Q26829790-DC62D012-40A1-458F-9833-0CA702624018 Q26853263-61EA1C7C-BFD0-4066-BAF1-548B1648DB33 Q27027082-02F34855-61AD-444E-A25F-74B042B8B512 Q33616097-A11D4352-2B10-4AAE-AFCC-58F319BB1CEE Q33647738-5D8E9646-3410-4E26-8C78-AEBF7B22AE77 Q33747949-8F6AD509-3035-414C-B6D5-36D951382A31 Q34400562-6A3D6453-D127-466F-BA3C-89BC3F0F9250 Q34471200-FFF08454-0257-452C-B00B-78616709FDAB Q34498875-B96A7CA3-0C6E-493A-BB7B-455FDCEA52D1 Q34687497-4ED39BFB-C806-49C4-BD9A-7B10BCF6B33E Q34963775-C2226B9E-165C-444E-8D44-E9B42345691A Q35219047-199FB9A0-BE18-41A6-B8C9-44944F3DB6EF Q35567841-E897D138-4E08-4C9F-A6E9-7895210A56B8 Q36205244-1506DE73-B9DD-48CE-8900-FC9F56553F2E Q36232275-3372B121-09C9-4BEB-B5E0-9A498396FBEC Q36340412-D54CB213-597A-4D7D-AB53-9B3AF61488FF Q37275159-A70C8389-B809-4D47-B7E3-E6A29BAE060E Q37280720-46DE0E35-92B0-4FF0-9BF1-A82227D3F54A Q37413246-B669E209-E82B-4114-BB67-B9FE7E2888F1 Q37831329-7F7ECA31-B154-4FD7-A382-424901F92292 Q38006826-FDF7626C-4152-49E4-970F-2C1158F77A45 Q38155650-6DED1146-2248-4853-8565-8B6B899A76F8 Q38541350-D59FB44C-482B-4F8B-9069-76245AA9C908 Q38591917-BD138037-8EAD-4635-9316-625C2A83032C Q38592520-47C01F9E-18CB-4030-802F-D4A47AE7FCF8 Q39100157-6A72D20A-AA52-4C97-BF20-92C4F9CF31B7 Q39186343-76BFE0E2-9DB2-49C7-A949-4DC9456B5FB8 Q39252265-8C22C726-CEEE-4884-8730-74C35E9CCD2F Q39331723-7ECC9544-ADF2-4178-BCE6-442E81E151F8 Q39598946-38880129-4B0F-4867-A1CA-413DFAD156E3 Q39998832-1DF35C68-2D44-4597-BD3D-E93D26134C84 Q40635614-9B9643E9-0331-4718-92FE-CDDD90AA499D Q40856216-92B9A0F1-6996-46FB-A296-B94F5EDBC0E6 Q41438903-3B5CBF3B-487E-4ABE-9544-07C1CA5C4EFC Q41497854-8FAE6BB2-5532-4A22-965B-49B4B8A56507 Q41652333-6A75553C-8B04-4AE6-B062-DCFCE015B819 Q43697611-AA8614C4-CF52-4774-9D8F-DF7C69C7FC0E Q46269173-CA6173B1-6D04-4BE4-9C5D-E995B155A1F2 Q46607642-07CAF81A-0F61-4869-B3F3-33612A24FDB6 Q47175243-A655A285-06D7-452A-A0CB-BBEAED128106

P2860

Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.

http://www.wikidata.org/entity/Q33745120

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Therapeutic targeting of class ...... erfusion-induced renal damage.

@ast

Therapeutic targeting of class ...... erfusion-induced renal damage.

@en

type

label

Therapeutic targeting of class ...... erfusion-induced renal damage.

@ast

Therapeutic targeting of class ...... erfusion-induced renal damage.

@en

prefLabel

Therapeutic targeting of class ...... erfusion-induced renal damage.

@ast

Therapeutic targeting of class ...... erfusion-induced renal damage.

@en

P1433

Q33745120-BE140BCE-2A4F-4475-9236-0D37929EBCEC

P1476

Q33745120-803EF169-36D0-4EC3-B354-5D628C326E5B

P2093

Q33745120-0DFA8106-2448-43E6-B9B9-BD0E6A986664

Q33745120-0F6110F0-7AD0-4D20-B541-C61833B73086

Q33745120-12D58B88-5571-4758-9017-28401428A0CA

Q33745120-5763F53C-A8B1-4912-B368-85BE3732DB84

Q33745120-68BBAA39-2AD6-4C27-AD82-77959380F802

Q33745120-9BA3C977-1BCD-4572-82ED-15C37A7E5E17

Q33745120-A59B3ED5-11CA-47AF-BC86-3B8C5BA88261

Q33745120-C6F21479-F069-408A-A345-2B507A0F9E7F

Q33745120-D90D7EF4-E9B0-4FD1-BC14-785200FF6AB6

Q33745120-DAC073C9-223D-4408-96F0-EE1B3E368B89

P2860

Q33745120-02475E5B-D94A-4DDB-9C93-63F8857513C2

Q33745120-05485101-E30E-40C2-9841-35E4E7E37A37

Q33745120-063C01B6-FD09-44F6-AC4E-B5214705AF75

Q33745120-11A86067-DBC6-41D1-9606-90071CE52447

Q33745120-14C23DF3-1FBA-45D6-BB5B-54EADD46A217

Q33745120-23B9AC12-31B3-4FC9-9B44-1389D8446AD6

Q33745120-2A8A4120-B58C-4A97-80AA-A30A6462C2B0

Q33745120-36B85764-EE25-4EBE-9F8F-E903BB86A691

Q33745120-3729B63D-10E4-406B-BA3F-9F81029AFB0B

Q33745120-4E92950A-8E56-403C-AD48-3A500B32E264

P304

Q33745120-4A67CC0E-0CD6-47E6-89C6-10938D10CDA2

P31

Q33745120-2C7CDEE1-6527-4F42-90E3-E831F8375E15

P356

Q33745120-0CAE4773-58FE-446B-A7D1-F54D33B714FA

P407

Q33745120-F6EAB253-784F-4300-AC87-CB7778930143

P433

Q33745120-E6F2EE67-B3B1-49AC-B87F-E98B9684D752

P478

Q33745120-BC601D96-5868-4486-A94A-36F8FE5F3B9F

P50

Q33745120-1413E3D9-7505-4208-9768-D1F4E232B034

Q33745120-15AD5BE6-1142-422D-9269-3EE6B1F6905A

Q33745120-983B294A-EC81-4F3A-9DFB-DCE4983AB67C

Q33745120-99D7E527-FA5C-4FA8-96EF-B8196687570C

Q33745120-AA876A2A-C555-4838-B687-77A849DCC3CE

Q33745120-C914E18C-9902-4483-84C8-380B6650A4C9

P577

Q33745120-D003BBBA-CF73-4341-8440-C6FDF8AD139E

P5875

Q33745120-BC7FDEB5-7673-4F2D-844F-473F6ABFA107

P698

Q33745120-027F63C0-DAEF-4F67-9904-FD1CDF9A45C3

P932

Q33745120-AD6E5B58-6B01-4CE1-A8C7-88DAD2FD1F75

P356

AJPATH.2010.090276

P1433

The American Journal of Pathology

P1476

Therapeutic targeting of class ...... erfusion-induced renal damage.

@en

P2093

Antonia Loverre

http://www.w3.org/2001/XMLSchema#string

Francesco Paolo Schena

http://www.w3.org/2001/XMLSchema#string

Francesco Paolo Selvaggi

http://www.w3.org/2001/XMLSchema#string

Gennaro Annunziata

http://www.w3.org/2001/XMLSchema#string

Giuseppe Grandaliano

http://www.w3.org/2001/XMLSchema#string

Maurice Mannesse

http://www.w3.org/2001/XMLSchema#string

Michele Rossini

http://www.w3.org/2001/XMLSchema#string

Mohamed R Daha

http://www.w3.org/2001/XMLSchema#string

Pasquale Ditonno

http://www.w3.org/2001/XMLSchema#string

Rita Melchiorre

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1

Complement. First of two parts

Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model

C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis

BIOLOGICAL ACTIVITIES OF C1 INHIBITOR

Local and remote ischemia-reperfusion injury is mitigated in mice overexpressing human C1 inhibitor.

Complement-targeted therapeutics

Role of the complement system in rejection.

DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes.

The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q

P304

1648-1659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.090276

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Lucarelli

Francesco Staffieri

Michele Battaglia

Giuseppe Castellano

Antonio Crovace

P577

2010-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41424842

http://www.w3.org/2001/XMLSchema#string

P698

20150432

http://www.w3.org/2001/XMLSchema#string

P932

2843457

http://www.w3.org/2001/XMLSchema#string